Andreas Halvorsen’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,594,326
Closed -$57.1M 90
2023
Q2
$57.1M Sell
1,594,326
-944,563
-37% -$27.1M 0.23% 72
2023
Q1
$59.5M Sell
2,538,889
-1,568,755
-38% -$44.8M 0.28% 58
2022
Q4
$112M Buy
4,107,644
+272,034
+7% +$12.4M 0.56% 47
2022
Q3
$206M Sell
3,835,610
-643,410
-14% -$33M 0.95% 36
2022
Q2
$181M Sell
4,479,020
-1,333,214
-23% -$66.1M 0.83% 40
2022
Q1
$385M Buy
5,812,234
+737,845
+15% +$50.5M 1.56% 22
2021
Q4
$508M Buy
5,074,389
+179,453
+4% +$18.6M 1.46% 21
2021
Q3
$612M Buy
4,894,936
+638,573
+15% +$75.9M 1.68% 18
2021
Q2
$529M Buy
4,256,363
+1,338,140
+46% +$180M 1.6% 23
2021
Q1
$445M Sell
2,918,223
-616,619
-17% -$93.2M 1.33% 30
2020
Q4
$456M Sell
3,534,842
-320,051
-8% -$36.8M 1.25% 28
2020
Q3
$431M Buy
3,854,893
+786,720
+26% +$72M 1.56% 22
2020
Q2
$249M Sell
3,068,173
-730,277
-19% -$58.8M 1.08% 31
2020
Q1
$264M Sell
3,798,450
-36,303
-0.9% -$2.79M 1.38% 26
2019
Q4
$300M Buy
3,834,753
+960,325
+33% +$69.2M 1.4% 21
2019
Q3
$183M Buy
+2,874,428
New +$253M 0.96% 28

Other funds holding GH

Andreas Halvorsen's GH Position: Q3 2023 in Review

Andreas Halvorsen sold out of Guardant Health (GH) in Q3 2023, closing a stake of 1,594,326 shares — an estimated $57.1M sold.

Andreas Halvorsen first reported a position in GH in Q3 2019 and held it in 16 quarters. The position peaked at $612M in Q3 2021. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

  • Andreas Halvorsen reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
  • Andreas Halvorsen sold 1,594,326 Guardant Health shares in Q3 2023, an estimated $57.1M.
  • Andreas Halvorsen first reported a position in Guardant Health in Q3 2019 and held it in 16 quarters.
  • Andreas Halvorsen's Guardant Health position peaked at $612M in Q3 2021.
  • 296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on Viking Global Investors's 13F filing for Q3 2023, filed 14 Nov 2023.